-nitroso-N-acetyl-penicillamine (SNAP)], an adenosine A1 receptor agonist [2-chloro-N 6 -cyclopentyladenosine (CCPA)], and a ␦1-opioid receptor agonist (TAN-670). The mice were subjected to a 30-min coronary occlusion followed by 24 h of reperfusion. In iNOS knockout (iNOS Ϫ/Ϫ ) mice, infarct size was similar to wild-type (WT) controls, indicating that iNOS does not modulate infarct size in the absence of PC. Pretreatment of WT mice with DETA/NO, NTG, SNAP, TAN-670, or CCPA 24 h before coronary occlusion markedly reduced infarct size. In iNOS Ϫ/Ϫ mice, however, the late PC effect elicited by DETA/NO, NTG, SNAP, TAN-670, and CCPA was completely abrogated. Furthermore, in WT mice pretreated with TAN-670 or CCPA, the selective iNOS inhibitor 1400W also abolished the delayed PC properties of these drugs; 1400W had no effect in WT mice. These data demonstrate that iNOS plays an obligatory role in NO donor-induced, adenosine A1 receptor agonist-induced, and ␦1-opioid receptor agonist-induced late PC, underscoring the critical role of this enzyme as a common mediator of cardiac adaptations to stress. nitric oxide; inducible nitric oxide synthase; myocardial ischemia; reperfusion injury ISCHEMIC PRECONDITIONING (PC), the phenomenon whereby brief episodes of ischemia render the heart resistant to subsequent ischemic insults, is a powerful innate cardioprotective mechanism. The late phase of PC is particularly relevant because once induced, it confers cardioprotection for 3-4 days (1, 5). Research performed in the past 10 years has identified nitric oxide (NO) as both a trigger and a mediator of the late phase of ischemic PC (6). In particular, Guo et al. (12) have demonstrated that genetic disruption of the iNOS gene completely abrogates the infarct-sparing effect of ischemia-induced late PC, establishing inducible NO synthase (iNOS) as an obligatory mediator.The cardioprotection afforded by ischemia-induced late PC can be mimicked by the administration of a variety of pharmacological agents, including NO-releasing agents (16,19,23,24), adenosine A 1 receptor agonists (2,3,22,27), and ␦ 1 -opioid receptor agonists (10), in dogs, rabbits, and mice. However, the mechanism of pharmacologically induced late PC, and the role of iNOS in particular, remains unclear. Although iNOS is a necessary mediator of ischemia-induced late PC (4), its role in NO donor-induced late PC is presently unknown. A recent study (16) concluded that iNOS mediates morphine-induced late PC in mice, but the short duration of reperfusion (2 h) may not have afforded accurate assessment of final infarct size. In addition, controversy exists as to whether adenosine A 1 agonist-induced late PC is mediated by iNOS. Bell et al. (3) concluded that iNOS is not obligatorily required for the development of late PC induced by adenosine A 1 agonists, whereas Zhao et al. (27) arrived at the opposite conclusion. Both of these studies were performed with the use of in vitro models of global ischemia. To date, the role of iNOS in adenosine A 1 agonist-induced late P...